文献速递妇科

育龄期早期宫颈癌女性的宫颈切除术:微创手术与开腹手术的比较

Trachelectomy for reproductive-aged women with early-stage cervical cancer: minimally invasive surgery versus laparotomy.
PubMed 文献 · Am J Obstet Gynecol · 2019-02-22

这项回顾性研究分析2010至2015年美国国家癌症数据库246例50岁以下IA2-IB期宫颈癌行宫颈切除术的女性,微创手术占58.5%,其使用率从2010年29.3%升至2015年75.0%,微创与开腹组死亡比例无显著差异(3.5% vs 7.6%,P=.25),作者认为微创对生存的影响仍未知、需进一步研究。

要点

  • 微创宫颈切除术使用率从2010年29.3%升至2015年75.0%(P<.001),2011年起成为主要术式(54.8%)。
  • 微创组死亡4例(3.5%),开腹组死亡7例(7.6%),两组比较P=.25,无显著差异。
  • 西部注册医院更倾向微创(75.0% vs 25.0%),中西部较少(46.9% vs 53.1%)(P=.02)。

核心结论

  • 2011年后微创手术成为育龄期IA2-IB期宫颈癌宫颈切除术的主要方式。
  • 无论手术方式如何,接受宫颈切除术的IA2-IB期宫颈癌女性生存总体良好。
  • 本研究显示微创与开腹手术生存无差异,但微创对生存的影响仍未知,需进一步研究。

研究设计与样本

  • 回顾性研究,分析2010至2015年美国国家癌症数据库。
  • 纳入50岁以下因IA2-IB期宫颈癌行宫颈切除术的女性,共246例,按手术方式分为微创手术组与开腹手术组。
  • 比较两组临床病理特征与结局。

主要发现

  • 246例中144例(58.5%,95%CI 52.4%-64.7%)采用微创手术。
  • 微创组与开腹组中位年龄相似(31岁 vs 29岁,P=.20)。
  • 微创手术使用率从2010年29.3%升至2015年75.0%(P<.001),2011年成为宫颈切除术主要方式(54.8%)。
  • 西部注册医院更倾向微创(75.0% vs 25.0%),中西部较少(46.9% vs 53.1%)(P=.02)。
  • 微创组中位随访37个月(四分位距23-51),开腹组40个月(四分位距26-67);随访期间共11例(5.3%)死亡,微创组4例(3.5%),开腹组7例(7.6%)(P=.25)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出微创手术对生存的影响仍未知,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A recent trial demonstrated decreased survival in women with early-stage cervical cancer who underwent radical hysterectomy via minimally invasive surgery compared with laparotomy; however, outcomes following trachelectomy have yet to be studied. OBJECTIVE: To examine trends, characteristics, and survival of reproductive-aged women with early-stage cervical cancer who underwent minimally invasive trachelectomy. STUDY DESIGN: This is a retrospective study examining the National Cancer Database between 2010 and 2015. Women aged <50 years who underwent trachelectomy for stage IA2-IB cervical cancer were grouped by mode of surgery. Clinicopathologic characteristics and outcomes were compared between minimally invasive surgery and laparotomy groups. RESULTS: A total of 246 women were included, 144 (58.5%, 95% confidence interval, 52.4%-64.7%) of whom had trachelectomy with a minimally invasive surgery approach. Median age was similar between the minimally invasive surgery and laparotomy groups (median, 31 vs 29 years, P = .20). There was a significant increase in the use of minimally invasive surgery from 29.3% in 2010 to 75.0% in 2015 (P < .001). Specifically, minimally invasive surgery became the dominant approach for trachelectomy by year 2011 (54.8%). Hospitals registered in the West (75.0% vs 25.0%) were more likely, whereas those registered in the Midwest (46.9% vs 53.1%) were less likely, to perform minimally invasive surgery (P = .02). Median follow-up was 37 months (interquartile range, 23-51) for the minimally invasive surgery group and 40 months (interquartile range, 26-67) for the laparotomy group. During follow-up, there were 11 (5.3%) deaths, 4 (3.5%) in the minimally invasive surgery group and 7 (7.6%) in the laparotomy group (P = .25). CONCLUSION: Minimally invasive surgery has become the dominant modality for trachelectomy in reproductive-aged women with stage IA2-IB cervical cancer after year 2011. Survival of women with stage IA2-IB cervical cancer who underwent trachelectomy is generally good regardless of surgical modality. Although our study showed no difference in survival between the minimally invasive surgery and laparotomy approaches, effects of MIS on survival remain unknown and further study is warranted.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Matsuo K, Chen L, Mandelbaum RS, et al. Trachelectomy for reproductive-aged women with early-stage cervical cancer: minimally invasive surgery versus laparotomy. Am J Obstet Gynecol. 2019. PMID: 30802438. doi:10.1016/j.ajog.2019.02.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。